The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT) OAV101 IT ...
Ist Ihre Schulklasse aus der Schweiz oder dem benachbarten Ausland an einem abwechslungsreichen und lehrreichen Laborerlebnis interessiert? Dann bietet das Novartis SchoolLab die optimale Möglichkeit ...
At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ...
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each ...